Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REVEFENACIN vs REZAFUNGIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REVEFENACIN vs REZAFUNGIN: Safety Overview

Metric REVEFENACIN REZAFUNGIN
Total FAERS Reports 280 108
Deaths Reported 11 12
Death Rate 3.9% 11.1%
Hospitalizations 23 20
Average Patient Age 72.4 yrs 53.8 yrs
% Female Patients 59.1% 54.3%
FDA Approval Date Nov 9, 2018 Mar 22, 2023
Manufacturer Viatris Specialty LLC Melinta Therapeutics, LLC
Route RESPIRATORY (INHALATION) INTRAVENOUS
Marketing Status Prescription Prescription